A new screening tool can identify the hidden driver of a silent killer through standard blood work, bypassing the need to ask ...

Johnson & Johnson (NYSE: JNJ) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for subcutaneous amivantamab and hyaluronidase-lpuj as ...

New designation is based on data showing rapid and durable responses in a heavily pretreated patient population and expands the promise of RYBREVANT FASPRO beyond lung ...

Monthly dosing reduces treatment visits while maintaining established safety and efficacy1,2 Builds on RYBREVANT FASPRO FDA approval to deliver the simplest and fastest ...

Japan now offers ELEVIDYS gene therapy to children with Duchenne muscular dystrophy aged 3 years to less than 8 years- Company is eligible to receive a $40 million milestone payment upon first ...

Rheumatologist Dr Thomas Batty and haematologist Dr Emma Conway O'Brien describe a rational approach to investigating multifocal pain ...

Gabelli's John Belton joins 'Closing Bell Overtime' to talk what he is expecting out of Nvidia quarterly results.

A growing share of U.S. families is reconsidering tightly packed calendars as children express a strong preference for time ...

Conference call to provide business updates today, February 25 at 1:30 p.m. PT/4:30 p.m. ET. FOSTER CITY, Calif., February 25 ...

Add Yahoo as a preferred source to see more of our stories on Google. The North Carolina Department of Transportation announced plans to build elevated express lanes on Interstate 77 in South ...